PD850 - PREVALENCE OF MALNUTRITION AND SARCOPENIA IN ESOPHAGOGASTRIC CANCER PATIENTS: A MORPHOFUNCTIONAL ASSESSMENT

PD850

PREVALENCE OF MALNUTRITION AND SARCOPENIA IN ESOPHAGOGASTRIC CANCER PATIENTS: A MORPHOFUNCTIONAL ASSESSMENT

P. VILLALBA ARMARIO^1,*, M. Carpio Salmerón¹, C. Marín Sospedra¹, I. Martín Perez¹, M. Álvarez Martín¹, A. Pinos Blanco¹, A. Cayuela García¹, R. Cañas Angulo¹

¹Endocrinología y Nutrición, Complejo Hospitalario Cartagena, Murcia, Spain

Rationale: Esophagogastric cancer is associated with high risk of disease-related malnutrition (DRM) and muscle impairment. Morphofunctional assessment may detect alterations not identified by conventional evaluation. The aim of this study is to determine the incidence of malnutrition, sarcopenia, and sarcopenic obesity in patients with this condition.

Methods: Cross-sectional study including 34 patients with esophagogastric cancer referred to Nutrition Unit of Santa Lucia’s Hospital, Cartagena (Spain), from January 2025-February 2026. Nutritional status was evaluated according to Global Leadership Initiative on Malnutrition (GLIM) criteria. Morphofunctional assessment included handgrip strength, functional tests, and bioelectrical impedance vector analysis measuring skeletal muscle mass index, fat-free mass index, body cell mass index and phase angle. Sarcopenia was defined according to EWGSOP2 criteria. Sarcopenic obesity was classified according to the ESPEN-EASO consensus. Statistical analyses were performed using SPSS v24.

Results: Mean age was 64.7 years; 67.6% were male. DRM was present in 94.1%, severe in 70.6%. Low muscle mass was observed in 47.1% and dynapenia in 41.2%. Sarcopenia was identified in 26.5% and sarcopenic obesity in 8.8% (1 type I, 2 type II). Mean ASMI in sarcopenic patients was 6.17 ± 0.60 kg/m2, and mean phase angle was 4.94 ± 0.84° vs 5.44 ± 0.82° in non-sarcopenic patients.

Conclusion: DRM was highly prevalent and frequently severe. A substantial proportion also presented muscle impairment, including sarcopenia while sarcopenic obesity was identified in a minority of cases. These findings support systematic morphofunctional assessment in oncologic nutritional care.

Disclosure of Interest: None declared